20028-71-1 Usage
Uses
Used in Pharmaceutical Industry:
6-chloroquinazolin-2-amine is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of drugs with diverse therapeutic profiles. Its unique structure allows for the creation of compounds with potential applications in treating a variety of diseases and conditions.
Used in Agrochemical Industry:
In the agrochemical sector, 6-chloroquinazolin-2-amine serves as a crucial component in the production of agrochemicals, leveraging its chemical properties to enhance the effectiveness of pesticides, herbicides, and other crop protection agents. This contributes to improved agricultural yields and more sustainable farming practices.
Used in Medicinal Chemistry and Drug Discovery:
6-chloroquinazolin-2-amine is utilized as a structural element in medicinal chemistry for its potential to form the basis of new drug candidates. Its presence in molecular structures can influence pharmacokinetics and pharmacodynamics, leading to the discovery of innovative treatments and therapeutic agents.
Overall, 6-chloroquinazolin-2-amine's versatility in chemical synthesis and its potential to enhance the properties of both pharmaceuticals and agrochemicals underscore its importance in the development of new and improved products across these industries.
Check Digit Verification of cas no
The CAS Registry Mumber 20028-71-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,0,2 and 8 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 20028-71:
(7*2)+(6*0)+(5*0)+(4*2)+(3*8)+(2*7)+(1*1)=61
61 % 10 = 1
So 20028-71-1 is a valid CAS Registry Number.
20028-71-1Relevant academic research and scientific papers
NITROGEN HETEROCYCLIC COMPOUNDS USEFUL AS PDE10 INHIBITORS
-
Page/Page column 184-185, (2011/12/02)
Unsaturated nitrogen heterocyclic compounds of formula (I): (I), as defined in the specification, compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, Huntington's Disease, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.
